CEO interview: Expanded Access for CS1 approved by the FDA
06 Feb 2024Video
Our CEO Sten R. Sörensen comments on the recent approval for Expanded Access for CS1 by the FDA, in an interview with BioStock.
Tune in to hear more about this exciting news!